Your search:
330 result(s) in 0.05 s
-
DUKAS_187684069_NUR
AstraZeneca - Pharmacy - EU - US Tariff - Photo Illustration
The US instills a 15% tariff rate on the EU for pharmaceutical products. Medicines are the largest European exports to the US by value, and the EU accounts for approximately 60% of all pharmaceutical imports to the US. The AstraZeneca logo is seen with tablets, capsules, and syringes in this photo illustration in Brussels, Belgium, on August 9, 2025. (Photo by Jonathan Raa/NurPhoto) -
DUKAS_187631819_NUR
Mexico’s President Claudia Sheinbaum Holds Briefing
Mexican President Claudia Sheinbaum Pardo, accompanied by Mexico's Economic Minister Marcelo Ebrard Casaubon, Mexico's Health Minister David Kershenobich Stalnikowitz, Carnot Laboratories' director Edmundo Jimenez Luna, Bayer's director in Mexico Manuel Bravo Pereyra, AstraZeneca Mexico CEO Julio Ordaz, Michoacan Governor Alfredo Ramirez Bedolla, Artifibras CEO David Martinez Gomez Tagle, and Pharma Bayer de Mexico CEO Daniel Londero, pose for photos after the Plan Mexico briefing at the National Palace in Mexico City, Mexico, on August 7, 2025. (Photo by Luis Barron Grupo Eyepix/NurPhoto) -
DUKAS_187573178_NUR
EU - US - Pharma Tariff - Photo Illustration
The EU pays the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, seen in this photo illustration in Brussels, Belgium, on August 5, 2025. (Photo by Jonathan Raa/NurPhoto) -
DUKAS_187573176_NUR
EU - US - Pharma Tariff - Photo Illustration
The EU pays the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, seen in this photo illustration in Brussels, Belgium, on August 5, 2025. (Photo by Jonathan Raa/NurPhoto) -
DUKAS_187573174_NUR
EU - US - Pharma Tariff - Photo Illustration
The EU pays the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, seen in this photo illustration in Brussels, Belgium, on August 5, 2025. (Photo by Jonathan Raa/NurPhoto) -
DUKAS_187573172_NUR
EU - US - Pharma Tariff - Photo Illustration
The EU pays the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, seen in this photo illustration in Brussels, Belgium, on August 5, 2025. (Photo by Jonathan Raa/NurPhoto) -
DUKAS_187573170_NUR
EU - US - Pharma Tariff - Photo Illustration
The EU pays the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, seen in this photo illustration in Brussels, Belgium, on August 5, 2025. (Photo by Jonathan Raa/NurPhoto) -
DUKAS_187573168_NUR
EU - US - Pharma Tariff - Photo Illustration
The EU pays the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, seen in this photo illustration in Brussels, Belgium, on August 5, 2025. (Photo by Jonathan Raa/NurPhoto) -
DUKAS_187573166_NUR
EU - US - Pharma Tariff - Photo Illustration
The EU pays the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, seen in this photo illustration in Brussels, Belgium, on August 5, 2025. (Photo by Jonathan Raa/NurPhoto) -
DUKAS_187573164_NUR
EU - US - Pharma Tariff - Photo Illustration
The EU pays the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, seen in this photo illustration in Brussels, Belgium, on August 5, 2025. (Photo by Jonathan Raa/NurPhoto) -
DUKAS_187573162_NUR
EU - US - Pharma Tariff - Photo Illustration
The EU pays the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, seen in this photo illustration in Brussels, Belgium, on August 5, 2025. (Photo by Jonathan Raa/NurPhoto) -
DUKAS_187573160_NUR
EU - US - Pharma Tariff - Photo Illustration
The EU pays the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, seen in this photo illustration in Brussels, Belgium, on August 5, 2025. (Photo by Jonathan Raa/NurPhoto) -
DUKAS_187573158_NUR
EU - US - Pharma Tariff - Photo Illustration
The EU pays the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, seen in this photo illustration in Brussels, Belgium, on August 5, 2025. (Photo by Jonathan Raa/NurPhoto) -
DUKAS_187116214_NUR
Pharmaceutical Company Booth at 3rd CISCE in Beijing
Visitors view the AstraZeneca booth at the 3rd China International Supply Chain Expo in Beijing, China, on July 20, 2025. (Photo by Costfoto/NurPhoto) -
DUKAS_176049745_EYE
Prime minister Keir Starmer meets Pascal Soriot
07/10/2024. London, United Kingdom. Prime minister Keir Starmer meets with Chief Executive Officer of AstraZeneca Pascal Soriot, alongside the Chancellor of the Exchequer Rachel Reeves and Secretary of State for Health and Social Care Wes Streeting in 10 Downing Street. Picture by Alice Hodgson / No 10 Downing Street / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
Crown copyright. Licensed under the Open Government Licence -
DUKAS_176049765_EYE
Prime minister Keir Starmer meets Pascal Soriot
07/10/2024. London, United Kingdom. Prime minister Keir Starmer meets with Chief Executive Officer of AstraZeneca Pascal Soriot, alongside the Chancellor of the Exchequer Rachel Reeves and Secretary of State for Health and Social Care Wes Streeting in 10 Downing Street. Picture by Alice Hodgson / No 10 Downing Street / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
Crown copyright. Licensed under the Open Government Licence -
DUKAS_167245946_EYE
Health Secretary Victoria Atkins visits CCRC and AstraZeneca
08/03/2024. London, United Kingdom. The Health Secretary Victoria Atkins visits Cambridge Clinical Research Facility (CRF) and AstraZeneca at Cambridge University Hospital. Picture by Tim Hammond / No 10 Downing Street / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
Crown copyright. Licensed under the Open Government Licence -
DUKAS_167245948_EYE
Health Secretary Victoria Atkins visits CCRC and AstraZeneca
08/03/2024. London, United Kingdom. The Health Secretary Victoria Atkins visits Cambridge Clinical Research Facility (CRF) and AstraZeneca at Cambridge University Hospital. Picture by Tim Hammond / No 10 Downing Street / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
Crown copyright. Licensed under the Open Government Licence -
DUKAS_167245921_EYE
Health Secretary Victoria Atkins visits CCRC and AstraZeneca
08/03/2024. London, United Kingdom. The Health Secretary Victoria Atkins visits Cambridge Clinical Research Facility (CRF) and AstraZeneca at Cambridge University Hospital. Picture by Tim Hammond / No 10 Downing Street / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
Crown copyright. Licensed under the Open Government Licence -
DUKAS_167245925_EYE
Health Secretary Victoria Atkins visits CCRC and AstraZeneca
08/03/2024. London, United Kingdom. The Health Secretary Victoria Atkins visits Cambridge Clinical Research Facility (CRF) and AstraZeneca at Cambridge University Hospital. Picture by Tim Hammond / No 10 Downing Street / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
Crown copyright. Licensed under the Open Government Licence -
DUKAS_167245947_EYE
Health Secretary Victoria Atkins visits CCRC and AstraZeneca
08/03/2024. London, United Kingdom. The Health Secretary Victoria Atkins visits Cambridge Clinical Research Facility (CRF) and AstraZeneca at Cambridge University Hospital. Picture by Tim Hammond / No 10 Downing Street / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
Crown copyright. Licensed under the Open Government Licence -
DUKAS_167245924_EYE
Health Secretary Victoria Atkins visits CCRC and AstraZeneca
08/03/2024. London, United Kingdom. The Health Secretary Victoria Atkins visits Cambridge Clinical Research Facility (CRF) and AstraZeneca at Cambridge University Hospital. Picture by Tim Hammond / No 10 Downing Street / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
Crown copyright. Licensed under the Open Government Licence -
DUKAS_167245931_EYE
Health Secretary Victoria Atkins visits CCRC and AstraZeneca
08/03/2024. London, United Kingdom. The Health Secretary Victoria Atkins visits Cambridge Clinical Research Facility (CRF) and AstraZeneca at Cambridge University Hospital. Picture by Tim Hammond / No 10 Downing Street / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
Crown copyright. Licensed under the Open Government Licence -
DUKAS_167245927_EYE
Health Secretary Victoria Atkins visits CCRC and AstraZeneca
08/03/2024. London, United Kingdom. The Health Secretary Victoria Atkins visits Cambridge Clinical Research Facility (CRF) and AstraZeneca at Cambridge University Hospital. Picture by Tim Hammond / No 10 Downing Street / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
Crown copyright. Licensed under the Open Government Licence -
DUK10147151_015
NEWS - Coronavirus: Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport
Impfaktion beim Pressetermin zur außergewöhnlichen Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport. Das Flugzeug wurde bis 2014 zur Simulation von Schwerelosigkeit bei sog. Parabelflügen eingesetzt. Köln, 21.12.2021 *** Local Caption *** 36805520
(c) Dukas -
DUK10147151_014
NEWS - Coronavirus: Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport
Impfaktion beim Pressetermin zur außergewöhnlichen Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport. Das Flugzeug wurde bis 2014 zur Simulation von Schwerelosigkeit bei sog. Parabelflügen eingesetzt. Köln, 21.12.2021 *** Local Caption *** 36805525
(c) Dukas -
DUK10147151_013
NEWS - Coronavirus: Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport
Hinweisschild zur Impfaktion beim Pressetermin zur außergewöhnlichen Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport. Das Flugzeug wurde bis 2014 zur Simulation von Schwerelosigkeit bei sog. Parabelflügen eingesetzt. Köln, 21.12.2021 *** Local Caption *** 36805501
(c) Dukas -
DUK10147151_012
NEWS - Coronavirus: Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport
Impfaktion beim Pressetermin zur außergewöhnlichen Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport. Das Flugzeug wurde bis 2014 zur Simulation von Schwerelosigkeit bei sog. Parabelflügen eingesetzt. Köln, 21.12.2021 *** Local Caption *** 36805533
(c) Dukas -
DUK10147151_011
NEWS - Coronavirus: Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport
Impfaktion beim Pressetermin zur außergewöhnlichen Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport. Das Flugzeug wurde bis 2014 zur Simulation von Schwerelosigkeit bei sog. Parabelflügen eingesetzt. Köln, 21.12.2021 *** Local Caption *** 36805515
(c) Dukas -
DUK10147151_010
NEWS - Coronavirus: Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport
A300 Zero G beim Pressetermin zur außergewöhnlichen Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport. Das Flugzeug wurde bis 2014 zur Simulation von Schwerelosigkeit bei sog. Parabelflügen eingesetzt. Köln, 21.12.2021 *** Local Caption *** 36805505
(c) Dukas -
DUK10147151_009
NEWS - Coronavirus: Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport
Impfaktion beim Pressetermin zur außergewöhnlichen Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport. Das Flugzeug wurde bis 2014 zur Simulation von Schwerelosigkeit bei sog. Parabelflügen eingesetzt. Köln, 21.12.2021 *** Local Caption *** 36805512
(c) Dukas -
DUK10147151_008
NEWS - Coronavirus: Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport
A300 Zero G beim Pressetermin zur außergewöhnlichen Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport. Das Flugzeug wurde bis 2014 zur Simulation von Schwerelosigkeit bei sog. Parabelflügen eingesetzt. Köln, 21.12.2021 *** Local Caption *** 36805541
(c) Dukas -
DUK10147151_007
NEWS - Coronavirus: Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport
Fläschchen mit Dosierungen von Comirnaty beim Pressetermin zur außergewöhnlichen Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport. Das Flugzeug wurde bis 2014 zur Simulation von Schwerelosigkeit bei sog. Parabelflügen eingesetzt. Köln, 21.12.2021 *** Local Caption *** 36805531
(c) Dukas -
DUK10147151_006
NEWS - Coronavirus: Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport
Impfaktion beim Pressetermin zur außergewöhnlichen Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport. Das Flugzeug wurde bis 2014 zur Simulation von Schwerelosigkeit bei sog. Parabelflügen eingesetzt. Köln, 21.12.2021 *** Local Caption *** 36805521
(c) Dukas -
DUK10147151_005
NEWS - Coronavirus: Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport
Hinweisschild zur Impfaktion beim Pressetermin zur außergewöhnlichen Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport. Das Flugzeug wurde bis 2014 zur Simulation von Schwerelosigkeit bei sog. Parabelflügen eingesetzt. Köln, 21.12.2021 *** Local Caption *** 36805546
(c) Dukas -
DUK10147151_004
NEWS - Coronavirus: Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport
Impfaktion beim Pressetermin zur außergewöhnlichen Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport. Das Flugzeug wurde bis 2014 zur Simulation von Schwerelosigkeit bei sog. Parabelflügen eingesetzt. Köln, 21.12.2021 *** Local Caption *** 36805534
(c) Dukas -
DUK10147151_003
NEWS - Coronavirus: Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport
Impfaktion beim Pressetermin zur außergewöhnlichen Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport. Das Flugzeug wurde bis 2014 zur Simulation von Schwerelosigkeit bei sog. Parabelflügen eingesetzt. Köln, 21.12.2021 *** Local Caption *** 36805492
(c) Dukas -
DUK10147151_001
NEWS - Coronavirus: Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport
Impfaktion beim Pressetermin zur außergewöhnlichen Impfaktion im historischen Airbus A300 Zero G am Köln Bonn Airport. Das Flugzeug wurde bis 2014 zur Simulation von Schwerelosigkeit bei sog. Parabelflügen eingesetzt. Köln, 21.12.2021 *** Local Caption *** 36805523
(c) Dukas -
DUKAS_132263499_EYE
‘Follow the science’: AstraZeneca unveils £1bn R&D centre. Anglo-Swedish pharmaceutical company has come a long way since it fought off a takeover bid in 2014
AstraZeneca unveils The Discovery Centre (DISC) in Cambridge
Image of the centre.
Little expense has been spared at the giant glass and steel structure that sprouts from a once-vacant plot of land on the outskirts of Cambridge.
AstraZeneca’s £1bn new research and development centre houses 16 labs and 2,200 scientists, making it the biggest science lab in Britain along with the Francis Crick Institute in London, and the pharmaceutical company’s biggest single site investment to date. Designed by the Swiss architects Herzog & de Meuron, the Discovery Centre (Disc) covers an area the size of eight football pitches, and is part of Europe’s biggest biomedical cluster. Cambridge University, two hospitals and hundreds of research institutions and biotech firms are nearby. The building is flooded with natural light, captures its heat from the ground beneath, and its toilets are flushed with rain water.
© Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_132263445_EYE
‘Follow the science’: AstraZeneca unveils £1bn R&D centre. Anglo-Swedish pharmaceutical company has come a long way since it fought off a takeover bid in 2014
AstraZeneca unveils The Discovery Centre (DISC) in Cambridge
Image of the centre.
Little expense has been spared at the giant glass and steel structure that sprouts from a once-vacant plot of land on the outskirts of Cambridge.
AstraZeneca’s £1bn new research and development centre houses 16 labs and 2,200 scientists, making it the biggest science lab in Britain along with the Francis Crick Institute in London, and the pharmaceutical company’s biggest single site investment to date. Designed by the Swiss architects Herzog & de Meuron, the Discovery Centre (Disc) covers an area the size of eight football pitches, and is part of Europe’s biggest biomedical cluster. Cambridge University, two hospitals and hundreds of research institutions and biotech firms are nearby. The building is flooded with natural light, captures its heat from the ground beneath, and its toilets are flushed with rain water.
© Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_132263415_EYE
‘Follow the science’: AstraZeneca unveils £1bn R&D centre. Anglo-Swedish pharmaceutical company has come a long way since it fought off a takeover bid in 2014
AstraZeneca unveils The Discovery Centre (DISC) in CambridgeAstraZeneca unveils The Discovery Centre (DISC) in Cambridge
Image captured during the speeches where HRH The Prince of Wales unveiled the plaque.
Little expense has been spared at the giant glass and steel structure that sprouts from a once-vacant plot of land on the outskirts of Cambridge.
AstraZeneca’s £1bn new research and development centre houses 16 labs and 2,200 scientists, making it the biggest science lab in Britain along with the Francis Crick Institute in London, and the pharmaceutical company’s biggest single site investment to date. Designed by the Swiss architects Herzog & de Meuron, the Discovery Centre (Disc) covers an area the size of eight football pitches, and is part of Europe’s biggest biomedical cluster. Cambridge University, two hospitals and hundreds of research institutions and biotech firms are nearby. The building is flooded with natural light, captures its heat from the ground beneath, and its toilets are flushed with rain water.
© Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_132263414_EYE
‘Follow the science’: AstraZeneca unveils £1bn R&D centre. Anglo-Swedish pharmaceutical company has come a long way since it fought off a takeover bid in 2014
AstraZeneca unveils The Discovery Centre (DISC) in CambridgeAstraZeneca unveils The Discovery Centre (DISC) in Cambridge
Image captured during the speeches where HRH The Prince of Wales unveiled the plaque.
Little expense has been spared at the giant glass and steel structure that sprouts from a once-vacant plot of land on the outskirts of Cambridge.
AstraZeneca’s £1bn new research and development centre houses 16 labs and 2,200 scientists, making it the biggest science lab in Britain along with the Francis Crick Institute in London, and the pharmaceutical company’s biggest single site investment to date. Designed by the Swiss architects Herzog & de Meuron, the Discovery Centre (Disc) covers an area the size of eight football pitches, and is part of Europe’s biggest biomedical cluster. Cambridge University, two hospitals and hundreds of research institutions and biotech firms are nearby. The building is flooded with natural light, captures its heat from the ground beneath, and its toilets are flushed with rain water.
© Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_132263346_EYE
‘Follow the science’: AstraZeneca unveils £1bn R&D centre. Anglo-Swedish pharmaceutical company has come a long way since it fought off a takeover bid in 2014
AstraZeneca unveils The Discovery Centre (DISC) in CambridgeAstraZeneca unveils The Discovery Centre (DISC) in Cambridge
Image captured during the speeches where HRH The Prince of Wales unveiled the plaque.
Little expense has been spared at the giant glass and steel structure that sprouts from a once-vacant plot of land on the outskirts of Cambridge.
AstraZeneca’s £1bn new research and development centre houses 16 labs and 2,200 scientists, making it the biggest science lab in Britain along with the Francis Crick Institute in London, and the pharmaceutical company’s biggest single site investment to date. Designed by the Swiss architects Herzog & de Meuron, the Discovery Centre (Disc) covers an area the size of eight football pitches, and is part of Europe’s biggest biomedical cluster. Cambridge University, two hospitals and hundreds of research institutions and biotech firms are nearby. The building is flooded with natural light, captures its heat from the ground beneath, and its toilets are flushed with rain water.
© Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_132263401_EYE
‘Follow the science’: AstraZeneca unveils £1bn R&D centre. Anglo-Swedish pharmaceutical company has come a long way since it fought off a takeover bid in 2014
AstraZeneca unveils The Discovery Centre (DISC) in CambridgeAstraZeneca unveils The Discovery Centre (DISC) in Cambridge
Image captured during the speeches where HRH The Prince of Wales unveiled the plaque.
Little expense has been spared at the giant glass and steel structure that sprouts from a once-vacant plot of land on the outskirts of Cambridge.
AstraZeneca’s £1bn new research and development centre houses 16 labs and 2,200 scientists, making it the biggest science lab in Britain along with the Francis Crick Institute in London, and the pharmaceutical company’s biggest single site investment to date. Designed by the Swiss architects Herzog & de Meuron, the Discovery Centre (Disc) covers an area the size of eight football pitches, and is part of Europe’s biggest biomedical cluster. Cambridge University, two hospitals and hundreds of research institutions and biotech firms are nearby. The building is flooded with natural light, captures its heat from the ground beneath, and its toilets are flushed with rain water.
© Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_132263398_EYE
‘Follow the science’: AstraZeneca unveils £1bn R&D centre. Anglo-Swedish pharmaceutical company has come a long way since it fought off a takeover bid in 2014
AstraZeneca unveils The Discovery Centre (DISC) in CambridgeAstraZeneca unveils The Discovery Centre (DISC) in Cambridge
Image captured during the speeches where HRH The Prince of Wales unveiled the plaque.
Little expense has been spared at the giant glass and steel structure that sprouts from a once-vacant plot of land on the outskirts of Cambridge.
AstraZeneca’s £1bn new research and development centre houses 16 labs and 2,200 scientists, making it the biggest science lab in Britain along with the Francis Crick Institute in London, and the pharmaceutical company’s biggest single site investment to date. Designed by the Swiss architects Herzog & de Meuron, the Discovery Centre (Disc) covers an area the size of eight football pitches, and is part of Europe’s biggest biomedical cluster. Cambridge University, two hospitals and hundreds of research institutions and biotech firms are nearby. The building is flooded with natural light, captures its heat from the ground beneath, and its toilets are flushed with rain water.
© Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_132263399_EYE
‘Follow the science’: AstraZeneca unveils £1bn R&D centre. Anglo-Swedish pharmaceutical company has come a long way since it fought off a takeover bid in 2014
AstraZeneca unveils The Discovery Centre (DISC) in CambridgeAstraZeneca unveils The Discovery Centre (DISC) in Cambridge
Image captured during the speeches where HRH The Prince of Wales unveiled the plaque.
Little expense has been spared at the giant glass and steel structure that sprouts from a once-vacant plot of land on the outskirts of Cambridge.
AstraZeneca’s £1bn new research and development centre houses 16 labs and 2,200 scientists, making it the biggest science lab in Britain along with the Francis Crick Institute in London, and the pharmaceutical company’s biggest single site investment to date. Designed by the Swiss architects Herzog & de Meuron, the Discovery Centre (Disc) covers an area the size of eight football pitches, and is part of Europe’s biggest biomedical cluster. Cambridge University, two hospitals and hundreds of research institutions and biotech firms are nearby. The building is flooded with natural light, captures its heat from the ground beneath, and its toilets are flushed with rain water.
© Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_132263351_EYE
‘Follow the science’: AstraZeneca unveils £1bn R&D centre. Anglo-Swedish pharmaceutical company has come a long way since it fought off a takeover bid in 2014
AstraZeneca unveils The Discovery Centre (DISC) in CambridgeAstraZeneca unveils The Discovery Centre (DISC) in Cambridge
Image captured during the speeches where HRH The Prince of Wales unveiled the plaque.
Little expense has been spared at the giant glass and steel structure that sprouts from a once-vacant plot of land on the outskirts of Cambridge.
AstraZeneca’s £1bn new research and development centre houses 16 labs and 2,200 scientists, making it the biggest science lab in Britain along with the Francis Crick Institute in London, and the pharmaceutical company’s biggest single site investment to date. Designed by the Swiss architects Herzog & de Meuron, the Discovery Centre (Disc) covers an area the size of eight football pitches, and is part of Europe’s biggest biomedical cluster. Cambridge University, two hospitals and hundreds of research institutions and biotech firms are nearby. The building is flooded with natural light, captures its heat from the ground beneath, and its toilets are flushed with rain water.
© Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_132263416_EYE
‘Follow the science’: AstraZeneca unveils £1bn R&D centre. Anglo-Swedish pharmaceutical company has come a long way since it fought off a takeover bid in 2014
AstraZeneca unveils The Discovery Centre (DISC) in CambridgeAstraZeneca unveils The Discovery Centre (DISC) in Cambridge
Image captured during the speeches where HRH The Prince of Wales unveiled the plaque.
Little expense has been spared at the giant glass and steel structure that sprouts from a once-vacant plot of land on the outskirts of Cambridge.
AstraZeneca’s £1bn new research and development centre houses 16 labs and 2,200 scientists, making it the biggest science lab in Britain along with the Francis Crick Institute in London, and the pharmaceutical company’s biggest single site investment to date. Designed by the Swiss architects Herzog & de Meuron, the Discovery Centre (Disc) covers an area the size of eight football pitches, and is part of Europe’s biggest biomedical cluster. Cambridge University, two hospitals and hundreds of research institutions and biotech firms are nearby. The building is flooded with natural light, captures its heat from the ground beneath, and its toilets are flushed with rain water.
© Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_132263349_EYE
‘Follow the science’: AstraZeneca unveils £1bn R&D centre. Anglo-Swedish pharmaceutical company has come a long way since it fought off a takeover bid in 2014
AstraZeneca unveils The Discovery Centre (DISC) in CambridgeAstraZeneca unveils The Discovery Centre (DISC) in Cambridge
Image captured during the speeches where HRH The Prince of Wales unveiled the plaque.
Little expense has been spared at the giant glass and steel structure that sprouts from a once-vacant plot of land on the outskirts of Cambridge.
AstraZeneca’s £1bn new research and development centre houses 16 labs and 2,200 scientists, making it the biggest science lab in Britain along with the Francis Crick Institute in London, and the pharmaceutical company’s biggest single site investment to date. Designed by the Swiss architects Herzog & de Meuron, the Discovery Centre (Disc) covers an area the size of eight football pitches, and is part of Europe’s biggest biomedical cluster. Cambridge University, two hospitals and hundreds of research institutions and biotech firms are nearby. The building is flooded with natural light, captures its heat from the ground beneath, and its toilets are flushed with rain water.
© Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_132263352_EYE
‘Follow the science’: AstraZeneca unveils £1bn R&D centre. Anglo-Swedish pharmaceutical company has come a long way since it fought off a takeover bid in 2014
AstraZeneca unveils The Discovery Centre (DISC) in CambridgeAstraZeneca unveils The Discovery Centre (DISC) in Cambridge
Image captured during the speeches where HRH The Prince of Wales unveiled the plaque.
Little expense has been spared at the giant glass and steel structure that sprouts from a once-vacant plot of land on the outskirts of Cambridge.
AstraZeneca’s £1bn new research and development centre houses 16 labs and 2,200 scientists, making it the biggest science lab in Britain along with the Francis Crick Institute in London, and the pharmaceutical company’s biggest single site investment to date. Designed by the Swiss architects Herzog & de Meuron, the Discovery Centre (Disc) covers an area the size of eight football pitches, and is part of Europe’s biggest biomedical cluster. Cambridge University, two hospitals and hundreds of research institutions and biotech firms are nearby. The building is flooded with natural light, captures its heat from the ground beneath, and its toilets are flushed with rain water.
© Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
